Erin L. Milliken, Ph.D.
Affiliations: | 2005 | Case Western Reserve University, Cleveland Heights, OH, United States |
Area:
Pharmacology, Animal Physiology Biology, Molecular Biology, OncologyGoogle:
"Erin Milliken"Parents
Sign in to add mentor| Ruth A. Keri | grad student | 2005 | Case Western | |
| (Use of a transgenic mouse model of ovarian hyperstimulation to identify therapeutic targets and mechanisms in hormone-induced mammary cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Milliken EL, Lozada KL, Johnson E, et al. (2008) Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer. Oncogene. 27: 1759-66 |
| Casadesus G, Milliken EL, Webber KM, et al. (2007) Increases in luteinizing hormone are associated with declines in cognitive performance. Molecular and Cellular Endocrinology. 269: 107-11 |
| Milliken EL, Zhang X, Flask C, et al. (2005) EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer. Cancer Letters. 229: 205-15 |
| Milliken EL, Ameduri RK, Landis MD, et al. (2002) Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice. Endocrinology. 143: 3671-80 |
| Ziady AG, Kelley TJ, Milliken E, et al. (2002) Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Molecular Therapy : the Journal of the American Society of Gene Therapy. 5: 413-9 |